NZ's EBOS not to proceed with Greencross acquisition (updated)

EBOS

21/11/2023 20:15

(Adds detail)
       Nov 22 (Reuters) - 
    Australasian pharmaceutical manufacturer EBOS Group  EBO.NZ 
said on Wednesday it would not proceed with a potential major
transaction in the animal care segment.
    The statement did not name its takeover target but local
media had reported the company would acquire TPG Capital-backed
pets and vets business Greencross.
    The Australian Financial Review reported that EBOS would pay
A$3.75 billion ($2.44 billion) to acquire Greencross, without
citing sources, and were set to raise about A$2 billion as early
as Wednesday. 
        In a stock exchange announcement, EBOS said "it has
recently been engaged in discussions regarding a potential
strategic transaction related to its Animal Care segment."
  
        "These discussions have now concluded and a transaction
will not proceed" 
  
    EBOS shares had been in a trading halt ahead of an
announcement related to the deal.
        
  


($1 = 1.5366 Australian dollars)

 (Reporting by Ayushman Ojha in Bengaluru
Editing by Marguerita Choy)
 ((Ayushman.ojha@thomsonreuters.com
;))